InvestorsHub Logo
Followers 23
Posts 1973
Boards Moderated 0
Alias Born 06/16/2017

Re: None

Thursday, 12/20/2018 5:27:16 AM

Thursday, December 20, 2018 5:27:16 AM

Post# of 32923
I believe I read in the Dec. 18th PR that the Goldman report won’t be about a simple buy or sell recommendation or a fluff price prediction but a more thorough accounting of the assets (NCM also), finances, a look into the preclinical research we aquired with NCM Biotech (medical/Pharma/CBD), future guidance of the direction of the company (this would be great). This is what we need, I want to hear more about the medical/Pharma side of this operation. $KALY